Interactions between the apolipoprotein E4 gene and modifiable risk factors for cognitive impairment: a nationally representative panel study

[1]  Joshua R. Ehrlich,et al.  Addition of Vision Impairment to a Life-Course Model of Potentially Modifiable Dementia Risk Factors in the US. , 2022, JAMA neurology.

[2]  Lin F. Yang,et al.  Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 , 2022, The Lancet. Public health.

[3]  Joshua R. Ehrlich,et al.  The Longitudinal Association of Vision Impairment with Transitions to Cognitive Impairment and Dementia: Findings from The Aging, Demographics and Memory Study. , 2021, The journals of gerontology. Series A, Biological sciences and medical sciences.

[4]  D. Llewellyn,et al.  Interaction between genetic predisposition, smoking, and dementia risk: a population-based cohort study , 2021, Scientific Reports.

[5]  M. He,et al.  The association between vision impairment and incidence of dementia and cognitive impairment: a systematic review and meta-analysis. , 2021, Ophthalmology.

[6]  G. Jicha,et al.  Association of Subjective Hearing Loss and Apolipoprotein E ε4 Allele on Alzheimer's Disease Neurodegeneration , 2020, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[7]  J. Faul,et al.  Considering the APOE locus in Alzheimer’s disease polygenic scores in the Health and Retirement Study: a longitudinal panel study , 2020, BMC medical genomics.

[8]  Naaheed Mukadam,et al.  Dementia prevention, intervention, and care: 2020 report of the Lancet Commission , 2020, The Lancet.

[9]  2020 Alzheimer's disease facts and figures , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[10]  T. Littlejohns,et al.  Association of Lifestyle and Genetic Risk With Incidence of Dementia. , 2019, JAMA.

[11]  K. Langa,et al.  The diagnosis and management of mild cognitive impairment: a clinical review. , 2014, JAMA.

[12]  Amanda Sonnega,et al.  Cohort Profile: the Health and Retirement Study (HRS). , 2014, International journal of epidemiology.

[13]  V. Pankratz,et al.  Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal , 2014, Neurology.

[14]  C. D’Arcy,et al.  Apolipoprotein E gene, environmental risk factors, and their interactions in dementia among seniors , 2013, International journal of geriatric psychiatry.

[15]  E. Mignot,et al.  Association of sleep disordered breathing and cognitive deficit in APOE ε4 carriers. , 2013, Sleep.

[16]  K. Langa,et al.  Incidence of dementia and cognitive impairment, not dementia in the united states , 2011, Annals of neurology.

[17]  H. Soininen,et al.  Midlife Smoking, Apolipoprotein E and Risk of Dementia and Alzheimer’s Disease: A Population-Based Cardiovascular Risk Factors, Aging and Dementia Study , 2010, Dementia and Geriatric Cognitive Disorders.

[18]  K. Langa,et al.  The Aging, Demographics, and Memory Study: Study Design and Methods , 2005, Neuroepidemiology.

[19]  C. Jack,et al.  Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.

[20]  H. Soininen,et al.  Incidence and Risk Factors for Mild Cognitive Impairment: A Population-Based Three-Year Follow-Up Study of Cognitively Healthy Elderly Subjects , 2004, Dementia and Geriatric Cognitive Disorders.

[21]  John Breitner,et al.  Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. , 2003, Archives of neurology.

[22]  L. Launer.  Demonstrating the case that AD is a vascular disease: epidemiologic evidence , 2002, Ageing Research Reviews.

[23]  W. Jagust,et al.  The Role of APOE ∊4 in Modulating Effects of Other Risk Factors for Cognitive Decline in Elderly Persons , 1999 .

[24]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[25]  Janice E Graham,et al.  Prevalence and severity of cognitive impairment with and without dementia in an elderly population , 1997, The Lancet.

[26]  D. Llewellyn,et al.  Physical Activity, APOE Genotype, and Cognitive Decline: Exploring Gene-Environment Interactions in the UK Biobank. , 2019, Journal of Alzheimer's disease : JAD.

[27]  Emily H. Trittschuh,et al.  Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia. , 2015, Journal of Alzheimer's disease : JAD.

[28]  R. Petersen,et al.  The apolipoprotein E genotype predicts longitudinal transitions to mild cognitive impairment but not to Alzheimer's dementia: findings from a nationally representative study. , 2013, Neuropsychology.

[29]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..